Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A3433 Gefitinib hydrochlorideTarget: EGFRSummary: Potent EGFR inhibitor
- A3573 LY2801653Target: METSummary: MET inhibitor
- A3632 MotesanibTarget: VEGFRSummary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
- B5859 EntrectinibTarget: Trk Receptors|ALK|ROS1Summary: Orally active inhibitor of ALK kinase
- A8310 PF-5622711 CitationTarget: FAK|Pyk2Summary: ATP-competitive FAK inhibitor, reversible
- A8320 PF-00562271Target: FAK|Pyk2Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
- A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
- A8345 PF-562271 HClTarget: FAK|Pyk2Summary: FAK/Pyk2 inhibitor
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met (WT/mutants) inhibitor
- A8219 Gefitinib (ZD1839)3 CitationTarget: EGFRSummary: Selective EGFR inhibitor